The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
To test the effect of Nexium and probiotics on insulin secretion and cardiovascular risk
factors on type 2 diabetic patients.
Study Hypothesis:
1. Nexium causes an increased gastrin secretion that increases the insulin secretion and
thereby a reduction of HbA1c
2. Probiotics changes the gut flora and bloodpressure
3. Probiotics causes a change in inflammation and thrombosis.
Phase:
Phase 3
Details
Lead Sponsor:
Lise Tarnow
Collaborators:
Chr Hansen Chr Hansen A/S Novo Nordisk A/S Statens Serum Institut Steno Diabetes Center Steno Diabetes Center Copenhagen